Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
10/2009
10/29/2009CA2722248A1 Hydrogensulfate salt of 2-acetoxy-5-(a-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine and its preparation
10/29/2009CA2722169A1 Factor ix conjugates with extended half-lives
10/29/2009CA2722028A1 5-hydroxypyrimidine-4-carboxamide compound
10/28/2009EP2112155A1 Hydrogensulfate salt of 2-acetoxy-5-(a-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine and its preparation
10/28/2009EP2111400A1 Pyridine compounds and their use as p2y12 antagonists.
10/28/2009EP1503800B1 Treatment and prevention of tissue damage associated with increased c-reactive protein production
10/28/2009EP1421539B1 Stabilized factor viii with engineered disulfide bonds
10/28/2009EP1404323B1 Use of methylnaltrexone to treat immune suppression
10/28/2009EP1379504B1 Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
10/28/2009EP1272168B2 Small organic molecule regulators of cell proliferation
10/28/2009EP0975340B2 Therapeutic inhibitor of vascular smooth muscle cells
10/28/2009EP0787181B1 Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof
10/28/2009CN101568334A Iron metabolism-improving agent
10/28/2009CN101565442A Novel estrogenic compound, preparation method and application thereof
10/28/2009CN101564465A Chinese medicinal composition for nourishing blood, benefiting vital energy, regulating menstruation and dissipating cold
10/28/2009CN101564463A Medicament for treating functional uterine hemorrhage
10/28/2009CN101564424A Common lamiophlomis root chewable tablet and preparation thereof
10/28/2009CN101564390A Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes
10/28/2009CN101564150A Health tea for promoting blood circulation and removing blood stasis of mid-aged and old people
10/28/2009CN101564074A Health tea for curing the edema of mid-aged and old people
10/28/2009CN100553678C Novel albumin-free factor VIII formulations
10/28/2009CN100553636C Method of using diketopiperazines and composition containing them
10/28/2009CN100553631C Pharmaceutical uses of 4-fluoro-N-(1,2- hydrindenl-2-yl) benzamide
10/27/2009US7608634 Substituted pyrrolines as kinase inhibitors
10/27/2009US7608633 1-(4-Octylphenoxy)-3-(pyrrol-1-yl)propan-2-one, for example; for preventing and treating diseases caused by an increased activity of this enzyme, such as inflammation, pain, fever, allergies, asthma, psoriasis and endotoxic shock
10/27/2009US7608621 Such as n-{[2-[(4-bromo-2-fluorophenyl)methyl]-5-hydroxy-6-(1-methylethyl)-3-oxo-2,3-dihydro-4-pyridazinyl]carbonyl}glycine; anemia; increasing erythropoietin production
10/27/2009US7608284 Active enamel matrix substance, such as an amelogenin, a processed amelogenin product, or a metabolite can be used in treating conditions in a mammal which present an imbalance in its native immune resposne to external or internal stimuli
10/27/2009US7608257 Using a reovirus and chemotherapeutic agents to treat ras-activated neoplastic cells; proliferative disorders
10/27/2009CA2466724C Benzamide and heteroarylamide as p2x7 receptor antagonists
10/27/2009CA2435426C Process for the preparation of (3-cyano-1h-indol-7-yl)(4-(4-fluorophenethyl)piperazin-1-yl)-methanone and salts thereof
10/27/2009CA2338141C Polymer complexes of glucuronoglucanes
10/27/2009CA2322171C Cyclic amino compounds
10/22/2009WO2009128795A1 Iron and zinc based pharmaceutical formulation for iron deficiency treatment
10/22/2009WO2009128558A1 Activator for peroxisome proliferator-activated receptor
10/22/2009WO2009128481A1 Nitrogenated 5-membered heterocyclic compound
10/22/2009WO2009128474A1 Method of producing thrombin-immobilized bioabsorbable sheet preparation
10/22/2009US20090264539 Fluoropolymer-based medical implant coating compositions
10/22/2009US20090264361 Identification of a family of secreted proteins in vascular endothelium
10/22/2009US20090264347 Use of Blood Coagulation Factor XIII for Treating Hemophilia A
10/22/2009US20090263474 Methods for Treating Autoimmune Diseases in a Subject and In Vitro Diagnostic Assays
10/22/2009US20090263401 USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE
10/22/2009US20090263388 Methods of preventing or treating cardiovascular, cerebrovascular and thrombotic disorders with tumor necrosis factor antagonists
10/22/2009US20090263380 Anti-idiotypic antibodies neutralizing the inhibitory activity of an inhibitory antibody directed against the c1 domain of factor viii
10/22/2009US20090263373 Non-neurotoxic plasminogen activating factors for treating of stroke
10/22/2009DE102008020197A1 Schnell benetzbares, Hydrokolloid enthaltendes Material, Verfahren zu dessen Herstellung sowie dessen Verwendung Quickly wettable, hydrocolloid-containing material, process for its preparation and its use
10/22/2009CA2721339A1 Activating agent for peroxisome proliferator activated receptor
10/22/2009CA2721335A1 Process for preparing bioabsorbable sheet preparation holding thrombin
10/21/2009EP2110385A1 Stabilized factor VIII with engineered disulfide bonds
10/21/2009EP2110136A2 Pharmaceutical composition for treating haemorrhagic shock and its consecutive symptoms
10/21/2009EP2110134A1 Cocoa extract compounds and methods for making and using the same
10/21/2009EP2109457A1 Therapeutic application of kazal-type serine protease inhibitors
10/21/2009EP1776138B1 tRNA SYNTHETASE FRAGMENTS
10/21/2009EP1450811B1 Compounds specific to adenosine A1 and A3 receptors and uses thereof
10/21/2009EP1423413B1 Peptidic compounds selectively binding to p-selectin
10/21/2009EP1280776B1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
10/21/2009EP1169062B1 Heat stable coated colloidal iron oxides
10/21/2009CN101560510A Agkistrodon acutus hemocoagulase atrox
10/21/2009CN101560478A Bacillus subtilis subso natto for producing natto kinase and application thereof
10/21/2009CN101560253A Method for the crystallization of human serum albumin
10/21/2009CN101560244A New method for synthesizing argatroban by combining solid phase method and liquid phase method
10/21/2009CN101560145A Method for separating chrysophanol and physcion by silica-gel column chromatography
10/21/2009CN101560126A Water-application quick floating oil pesticide and application method thereof
10/21/2009CN101559168A Pharmaceutical composition for invigorating Qi, tonifying blood and nourishing liver and kidney as well as preparation method and application thereof
10/21/2009CN101559152A Chinese materia medica preparation for treating hydrocephalus and preparation method thereof
10/21/2009CN101559142A Chinese wolfberry health care medicinal white spirit
10/21/2009CN101559078A Glue series medicine
10/21/2009CN101559059A Pharmaceutical composition containing amiloride hydrochloride and preparation method thereof
10/21/2009CN101559044A Clopidogrel hydrosulfate enteric coated tablet and preparation thereof
10/21/2009CN101559039A Method for producing nattokinase liposome from phytosterol
10/21/2009CN100551404C Preparing method for composition of medication for inducing diuresis to alleviate edema, detection method and usage
10/21/2009CN100551392C Decumbent corydalis Rhizome medicinal composition for treating cerebral thrombosis sequela and rheumatic arthritis
10/21/2009CN100551388C An injection containing phenylpropanolid glycosides, its preparation method and use
10/21/2009CN100551369C Sustained release preparation containing cilostazol and its preparation method
10/20/2009US7605179 administering vitamin k derivatives for prophylaxis of neurodegenerative diseases associated with protein aggregation or neurofibrillary tangles
10/20/2009US7605158 Carbamoyl-type benzofuran derivatives
10/20/2009US7605152 such as 16 alpha -fluoro-17 beta -hydroxy-4-methyl-4-aza-5 alpha -androst-1-en-3-one, used for hormone replacement therapy
10/20/2009CA2481593C Biologically stable liquid composition of fviii, of vwf or of fviii/vwf complex of human origin
10/20/2009CA2380986C Carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions
10/20/2009CA2380852C Tricyclic compounds having spiro union
10/15/2009WO2009126917A1 Method of providing hemostasis in anti-coagulated blood
10/15/2009WO2009126822A2 Methods of regulating actin cytoskeletal rearrangement and intercellular gap formation
10/15/2009WO2009126556A1 Pan-selectin inhibitor with enhanced pharmacokinetic activity
10/15/2009WO2009125365A1 2-phenyl-4-cyclopropyl-pyrimidine derivatives
10/15/2009WO2008104620A8 Use of matrix metalloproteinase-10 (mmp-10) for thrombolytic treatments
10/15/2009US20090258877 Triazolotriazines and triazolopyrazines and their use
10/15/2009US20090258054 Heparin Prodrugs and Drug Delivery Stents Formed Therefrom
10/15/2009US20090258029 Heparin Prodrugs and Drug Delivery Stents Formed Therefrom
10/15/2009US20090258004 Human blood proteins expressed in monocot seeds
10/15/2009DE202008003509U1 Pharmazeutische Zusammensetzung zur Prophylaxe und Behandlung der Arteriosklerose, sowie zur Schmerzbekämpfung und zur Entzündungshemmung A pharmaceutical composition for the prophylaxis and treatment of atherosclerosis, as well as pain relief and inflammation
10/15/2009CA2721082A1 Methods of regulating actin cytoskeletal rearrangement and intercellular gap formation
10/15/2009CA2720824A1 Improved quenching methods for red blood cell pathogen inactivation
10/15/2009CA2719569A1 2-phenyl-4-cyclopropyl-pyrimidine derivatives
10/14/2009EP2108659A1 Virally safe factor VIII with a low content of higher multimers
10/14/2009EP2108013A2 Crystalline forms of deferasirox
10/14/2009EP1554572B1 Compositions and methods for modulating blood-brain barrier transport
10/14/2009EP1461337B1 Pyrido¬2,1-a isoquinoline derivatives as dpp-iv inhibitors
10/14/2009EP1397137B1 Hydantion derivatives as inhibitors of matrix metalloproteinases
10/14/2009EP1331950B1 Ex vivo methods and compositions for nucleic acid delivery
10/14/2009EP1232257B1 Modular transport systems for molecular substances and production and use thereof
10/14/2009EP0734251B1 Method of transmitting a biologically active material to a cell
1 ... 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 ... 671